Paperpal Prime Logo

Epidemics : Impact Factor & More

eISSN: 1878-0067pISSN: 1755-4365
JournalOpen Access

Key Metrics

CiteScore
7.6
Eigenfactor
0.001 - 0.005
H-Index
49
Impact Factor
< 5
SJR
Q1Virology
SNIP
1.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Epidemics

Epidemics Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Quarterly
Article Processing ChargesUSD 2860
Publication Time47
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 47
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Epidemics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Epidemics

Seroprevalence convergence masks persistent socioeconomic disparities in SARS-CoV-2 infection risk in Canada.
  • 4 Aug 2026
  • Epidemics
Health and economic impact of introducing norovirus vaccination in England accounting for acute kidney injury: Model-based cost-effectiveness analysis.
  • 28 Jul 2026
  • Epidemics
Categorical short-term forecasts of respiratory pathogens in Europe.
  • 27 Jul 2026
  • Epidemics
Modeling the impact of adherence to U.S. isolation and masking guidance on SARS-CoV-2 transmission in office workplaces in 2021-2022.
  • 24 Jul 2026
  • Epidemics
Identifying the optimal schedule for a multi-pathogen combination vaccine for diarrheal disease.
  • 24 Jul 2026
  • Epidemics
Predicting contact rates in response to non-pharmaceutical interventions: A validated protocol for generating contact matrices relevant to transmission modelling of respiratory diseases.
  • 10 Jul 2026
  • Epidemics
Seroprevalence convergence masks persistent socioeconomic disparities in SARS-CoV-2 infection risk in Canada.
  • 4 Aug 2026
  • Epidemics
Health and economic impact of introducing norovirus vaccination in England accounting for acute kidney injury: Model-based cost-effectiveness analysis.
  • 28 Jul 2026
  • Epidemics
Categorical short-term forecasts of respiratory pathogens in Europe.
  • 27 Jul 2026
  • Epidemics
Modeling the impact of adherence to U.S. isolation and masking guidance on SARS-CoV-2 transmission in office workplaces in 2021-2022.
  • 24 Jul 2026
  • Epidemics
Identifying the optimal schedule for a multi-pathogen combination vaccine for diarrheal disease.
  • 24 Jul 2026
  • Epidemics
Predicting contact rates in response to non-pharmaceutical interventions: A validated protocol for generating contact matrices relevant to transmission modelling of respiratory diseases.
  • 10 Jul 2026
  • Epidemics

FAQs on Epidemics